What do PROs do
Compounding BPC-157: A regulatory loophole In a statement, Health Canada said "BPC157 has not been authorized, its safety, efficacy, and quality have not been assessed and there is limited scientific evidence to support its use, including a lack of established human dosing protocols." In addition, the regulator says BPC-157 is not approved for use in any NHPs in any form, including oral and injectable, but it can still be compounded for topical use or oral administration as an NHP
Fasted timing and storage Because MOTS-c works through AMPK and glucose uptake, many protocols time injections in a fasted state or before training to align with the exercise response
Ferroptosis can be pharmacologically induced through inhibition of system Xc - (e.g., erastin and its derivatives), direct inhibition of GPX4 (e.g., RSL3), or disruption of the FSP1-CoQ10 axis (97, 98)
ZhangDLeitmanMPawarSSheraSHernandezLJacobsJPet al